Reprogram cellular and protein interactions to enable targeted treatment and enhanced immune response.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Orionis Biosciences develops precision medicines by designing molecules that control interactions between proteins, cells, and the immune system to address complex diseases. It uses proprietary platforms that combine advanced biology, chemistry, and artificial intelligence to discover and engineer targeted therapies with improved selectivity and effectiveness. The company focuses on reprogramming disease processes and enhancing immune responses through innovative drug modalities.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Orionis Biosciences Management Team
Orionis Biosciences Valuations & Financials
View real-time NPM data on Orionis Biosciences stock including daily Orionis Biosciences stock price estimates, valuation history, and historical share price information. Access Orionis Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Orionis Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Orionis Biosciences? Get in touch to learn more.
Similar Companies
like Orionis Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Cato Networks
Cybersecurity
Provides a cloud-native SASE platform that unifies networking and security for secure, optimized, and simplified connectivity worldwide.
Unnatural Products
Healthcare & Life Sciences
Develops which macrocyclic compounds emulate natural molecules to reach challenging targets through AI-guided design and synthesis.
Curio
Media & Entertainment
Develops composable gaming infrastructure and strategy games featuring on-chain social agreements, prioritizing user-generated content.
RYSE
AI & Machine Learning
Effortlessly converts existing window coverings into automated smart shades with app and voice control.
Webull
FinTech
Offers commission-free trading services, providing users with advanced tools and global market access.
TRUFF
Consumer
A gourmet condiment brand that crafts truffle-infused sauces and pantry staples aimed at elevating everyday meals.
Calviri
Healthcare & Life Sciences
Provides multi‑cancer early detection and low‑cost vaccines to prevent or treat tumors.
RSI Inc
Industrials
Designs and installs custom commercial refrigeration systems with ongoing maintenance services to optimize cold storage and energy efficiency.
FAQ
We have answers
Orionis Biosciences stock does not trade on public stock exchanges. Orionis Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Orionis Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Orionis Biosciences Stock does not trade on public stock exchanges. In order to sell Orionis Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Orionis Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Orionis Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Orionis Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Orionis Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Orionis Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Orionis Biosciences is a private company and has not had an IPO. There is currently no Orionis Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Orionis Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
